November 9, 2017 7:34am
The question surrounds whether quarterly and financing uncertainties undermine sentiment
Let us not forget how HC Wainwright pre-announced Capricor’s (CAPR) current $14 M ATM financing completion
There is an under supply of reliable information about the sector …
Can’t read because of no subscription - you’re missing situational awareness and the most trustworthy source of independent insight!
Pre-open trading indications: 4 SELLs and 1 BUY
Quarterly financial results: BLFS, BTX, CLBS, CYTX, XON, ONVO, SGMO, STML, VTGN and HSGX
For continued access to what one industry CEO calls the “bible” for smart investing in the RegMed, gene and cell therapy sector’ … I’d recommend being a subscriber!
Is the truth so hard to fathom?
Members only. Please login.